Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000542303 | SCV000622186 | pathogenic | Fabry disease | 2023-08-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr152*) in the GLA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GLA are known to be pathogenic (PMID: 10666480, 12175777). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Fabry disease (PMID: 16595074, 24582695). ClinVar contains an entry for this variant (Variation ID: 453317). For these reasons, this variant has been classified as Pathogenic. |
Eurofins Ntd Llc |
RCV000727447 | SCV000708593 | pathogenic | not provided | 2017-05-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000542303 | SCV002054434 | pathogenic | Fabry disease | 2021-07-15 | criteria provided, single submitter | clinical testing |